1-3 of 3
Anna Enjuanes
Close
Sort by
Journal Articles

IGLV3-21 R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia

Charlotte Syrykh, Berta Pons-Brun, Núria Russiñol, Heribert Playa-Albinyana, Tycho Baumann, Martí Duran-Ferrer, Marta Kulis, Anna Carbó-Meix, Pablo Mozas, Miguel Alcoceba, Marcos González, Almudena Navarro-Bailón, Enrique Colado, Ángel R. Payer, Marta Aymerich, María J. Terol, Junyan Lu, Binyamin A. Knisbacher, Cynthia K. Hahn, Sílvia Ruiz-Gaspà, Anna Enjuanes, Catherine J. Wu, Gad Getz, Thorsten Zenz, Armando López-Guillermo, José I. Martín-Subero, Dolors Colomer, Julio Delgado, Elías Campo, Ferran Nadeu
Journal: Blood Advances
Blood Adv (2023) 7 (23): 7384–7391.
https://doi.org/10.1182/bloodadvances.2023010132
Published: 2023
Includes: Supplemental data
Journal Articles

Unraveling the genetics of transformed splenic marginal zone lymphoma

Marta Grau, Cristina López, Alba Navarro, Gerard Frigola, Ferran Nadeu, Guillem Clot, Gabriela Bastidas-Mora, Miguel Alcoceba, Maria Joao Baptista, Margarita Blanes, Dolors Colomer, Dolors Costa, Eva Domingo-Domènech, Anna Enjuanes, Lourdes Escoda, Pilar Forcada, Eva Giné, Mónica Lopez-Guerra, Olga Ramón, Alfredo Rivas-Delgado, Laura Vicente Folch, Andrew Wotherspoon, Fina Climent, Elias Campo, Armando López-Guillermo, Estella Matutes, Sílvia Beà
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3695–3709.
https://doi.org/10.1182/bloodadvances.2022009415
Published: 2023
Includes: Supplemental data
Journal Articles

PI3Kδ inhibition reshapes follicular lymphoma–immune microenvironment cross talk and unleashes the activity of venetoclax

Neus Serrat, Martina Guerrero-Hernández, Alba Matas-Céspedes, Anella Yahiaoui, Juan G. Valero, Ferran Nadeu, Guillem Clot, Miriam Di Re, Marc Corbera-Bellalta, Laura Magnano, Alfredo Rivas-Delgado, Anna Enjuanes, Silvia Beà, Maria C. Cid, Elías Campo, Joan Montero, Daniel J. Hodson, Armando López-Guillermo, Dolors Colomer, Stacey Tannheimer, Patricia Pérez-Galán
Journal: Blood Advances
Blood Adv (2020) 4 (17): 4217–4231.
https://doi.org/10.1182/bloodadvances.2020001584
Published: 2020
Includes: Supplemental data